EMA Authorised: Leflunomide ratiopharm (leflunomide) — Ratiopharm GmbH

View source ↗

Summary

Authorisation of Leflunomide Ratiopharm (leflunomide) for rheumatoid arthritis in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide ratiopharm (leflunomide)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid. MAH: Ratiopharm GmbH. Decision date: 28/07/2026